Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in amplified adverse effects including drowsiness, although the clinical relevance is minimal in the majority of sufferers – keep an eye on the individual for adverse effects (e.If affected person can't resume their standard oral